INTRODUCTION
Despite advances in obstetrics and increased orientation towards antenatal visits, preeclampsia and eclampsia remain unresolved and challenging in the field of obstetrics and are major contributors to maternal and perinatal mortality. to 2007 were from complications of pregnancy-related hypertension. In the UK, preeclampsia and eclampsia are the second largest cause of both direct maternal death and perinatal loss, responsible for the death of 6 to 9 women annually. 2 Hypertensive disorders of pregnancy are one of the leading causes of severe maternal mortality and morbidity approximately 6-8% of all pregnancies worldwide. 2, 3 These disorders are responsible for 20% of perinatal mortality. 4, 5 Until middle of the twentieth century there was staggeringly high maternal and perinatal mortality associated with eclampsia both in developed and developing countries. Thereafter, with worldwide innovation of Maternal and Child Health care concept, expert perinatal care, early detection of risk factors, high index of suspicion and extended liberal indication for hospitalization, there was dramatic reduction in the incidence and improved outcome of preeclampsia and eclampsia. However, this was observed only in developed countries ,whereas in developing countries where most of the patients are admitted in the hospital as an emergency case, lack of proper antenatal care and negligence due to illiteracy, superstition and low socioeconomic status this impact was minimal. 2, 6 According to NICE (National Institute for Health and Clinical Excellence) guidelines several risk factors are involved for the occurrence of hypertension during pregnancy. They include high risk factors such as history of hypertensive disease during a previous pregnancy, chronic kidney disease, auto-immune disease, type-1 or type-2 diabetes, chronic hypertension while the moderate risk factors include first pregnancy, age >40years, pregnancy interval >10years, body mass index >35kg/m 2 , family history of preeclampsia and multiple pregnancies. 7 Management of eclampsia has undergone a long trial from empirical to specific treatment viz. venesection, sedatives, cold packs till 1870, morphine, chloral hydrate etc. in early 20 th century and specific regimens from the middle of the 20 th century. 8 Thus, various drugs and regimens were introduced and quickly discarded.
Currently three major regimens are in practice such as Diazepam, Lytic cocktail and Magnesium Sulfate, with comparable results. The excellent results were obtained by Pritchard regimen (magnesium sulfate) in the management of eclamptic patients with low maternal mortality (0.4%) and good perinatal mortality (4%). 7, 9 Hence, we planned for the study on the management of eclampsia using Magnesium sulfate regimen.
METHODS
It was a prospective, observational and non-interventional study which was carried out in the obstetrics ward of Dhiraj Hospital which is a rural tertiary care teaching hospital affiliated with SBKS Medical Institute and Research Centre, under Sumandeep Vidyapeeth. The study was initiated only after obtaining an approval from institutional ethics committee of Sumandeep Vidyapeeth.
A written Informed Consent was obtained from the patients in the vernacular language after thorough explanation about the purpose and method of the study through Patient Information Sheet before enrolling them for this study. Relevant data was gathered from their case files and by direct interview with the patient. Information of all patients was recorded in Case Record Form. The data was analysed for pattern of prescription and drug use.
RESULTS
A total of 750 deliveries were recorded during our study period. Out of these recorded cases, 35 were diagnosed as patients of eclampsia and were treated accordingly. Thus making an incidence of eclampsia to be 4.6% (Figure 1 ). Of the recorded 35 patients of eclampsia 22 were primi gravida (62.85%) while 13(37.14%) were multigravida (Table 1, Figure 2 ). In relation to gestational age we found that 23 (65.71%) patients suffered during antepartum, 9 (25.71%) suffered during intrapartum, while 3 (11.1%) patients suffered in postpartum period (Table 2, Figure 3 ). 
DISCUSSION
Eclampsia remains as one of the leading causes for maternal and perinatal mortality. 10 In our study duration of 6 months, out of the 750 deliveries that were recorded 35 patients were found to be eclamptic, that makes the incidence of eclampsia to be 4.6%. Primigravida are more likely to develop eclampsia compared with the multigravida. 11 It has also been found in our study that most patients were of primigravida (28-37 years).
Although the disease condition is very old the cause still remains unclear. Several theories explain the cause of eclampsia which include; abnormal trophoblastic invasion of uterine vessels, immunological intolerance between maternal and fetoplacental tissue, maternal maladaptation to cardiovascular and inflammatory changes of normal pregnancy, nutritional deficiency and genetic influences. 11, 12 The cause of eclampsia being multifactorial the management has undergone a long trial from empirical to specific treatment. However, currently 3 regimens are in practise that includes diazepam, lytic cocktail and magnesium sulphate regimen, of all the above regimens it has been found that magnesium sulphate regimen is popularly used with good results. Magnesium sulfate regimens include Pritchard's regimen, Zuspan's regimen and Sibai regimen. 11, [13] [14] [15] In our study we found that all 35 cases were treated with Pritchard's regimen in which magnesium sulfate was initially administered 4gm IV, slowly over 5-10mins followed by 10gm deep IM. The maintenance dose included 5gm IM 4 th hourly for 24hrs. 13, 14 All patients improved with Pritchard's regimen. There was no maternal or foetal mortality recorded during the study period. There were no adverse events recorded at the time of management.
As it was the short term study and the number of eclamptic patients recorded during the study were 35 which do not reflect behavior of the general public. The study was planned to compare the effect of various regimes of magnesium sulphate in the treatment of eclampsia, however in our centre it was a limitation as only Pritchard's regimen was use for all 35 patients. A future study in larger population including urban and rural areas with comparison between states would give a real picture of the situation.
CONCLUSION
Even today in developing country like ours we find that cases of eclampsia continues to occur despite of the efforts taken to improve with the antenatal care. Although, various regimes and numerous newer antihypertensive drugs are available, magnesium sulphate remains to be safe and effective in the treatment of eclampsia.
Regular antenatal care, timely diagnosis and appropriate treatment would reduce the maternal and foetal mortality and related complications of eclampsia. Therefore, coordinated efforts are needed amongst the community, governmental and non-governmental organizations, medical and paramedical staff. More of the awareness programmes are to be conducted for the illiterate group and emphasis on ANC and its importance that would probably help us to come down with the incidence.
